(Q28181979)

9

object named as

Elsken van der Wall

0 references

Paul J van Diest

8

object named as

Paul J van Diest

0 references

Petra van der Groep

2

object named as

Petra van der Groep

0 references

author name string

Reinhard Bos

1

0 references

Astrid E Greijer

3

0 references

Avi Shvarts

4

0 references

Sybren Meijer

5

0 references

Herbert M Pinedo

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

6

0 references

language of work or name

English

0 references

publication date

15 March 2003

0 references

published in

Cancer

0 references

volume

97

0 references

issue

6

0 references

page(s)

1573-81

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

HIF-1: mediator of physiological and pathophysiological responses to hypoxia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Hypoxia, clonal selection, and the role of HIF-1 in tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Mechanical loading regulates expression of talin and its mRNA, which are concentrated at myotendinous junctions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Antiangiogenesis for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Causes and consequences of tumour acidity and implications for treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Prognosis and breast cancer. Recognition of lethal and favorable prognostic types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Quality control in immunocytochemistry: experiences with the oestrogen receptor assay

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Prognostic value of vascular endothelial growth factor in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11246

7 January 2021

Identifiers

DOI

10.1002/CNCR.11246

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12627523

1 reference

Consolidated OpenCitations Corpus – April 2017